Chang, M., Wu, J., Liao, H., Chen, Y., & Kuo, C. (2015). N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production. Anticancer Drugs.

Chang, Ming-Che, Jin-Yi Wu, Hui-Fen Liao, Yu-Jen Chen, a Cheng-Deng Kuo. "N-Farnesyloxy-norcantharimide Inhibits Progression of Human Leukemic Jurkat T Cells Through Regulation of Mitogen-activated Protein Kinase and Interleukin-2 Production." Anticancer Drugs 2015.

Chang, Ming-Che, et al. "N-Farnesyloxy-norcantharimide Inhibits Progression of Human Leukemic Jurkat T Cells Through Regulation of Mitogen-activated Protein Kinase and Interleukin-2 Production." Anticancer Drugs 2015.